Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VESICANS: Extracellular Vesicles in CAR-T Therapy and ICANS
NCT06706102Phase 4Recruiting
- Sponsor
- CHU Saint-Etienne
- Start
- Jul 2025
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by CHU Saint-Etienne. Primary endpoints: Endothelial Extracellular Vesicles quantification at Day 60 and Endothelial Extracellular Vesicles characterization at Day 60. Started Jul 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06706102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06706102.